Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7608693
High affinity human antibodies to human IL-4 receptor
granted -
US 7605237
High affinity human antibodies to human IL-4 receptor
granted -
US 7582298
High affinity antibodies to human IL-6 receptor
granted -
US 7576065
Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
granted -
US 7572893
IL-1 antagonist formulations
granted -
US 7557084
IL-18 specific polypeptides and therapeutic uses thereof
granted -
US 7534868
Human antibodies to human delta like ligand 4
granted -
US 7534604
Fusion polypeptides capable of activating receptors
granted -
US 7531172
Methods of treating diseases with a VEGF antagonist
granted -
US 7531173
Ophthalmic composition of a VEGF antagonist
granted -
US 7524499
Modified chimeric polypeptides with improved pharmacokinetic properties
granted -
US 7521211
IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof
granted -
US 7521049
Use of VEGF inhibitors for treatment of eye disorders
granted -
US 7488806
Human antibodies to human delta like ligand 4
granted -
US 7482002
Method of administering and using VEGF inhibitors for the treatment of prostate cancer
granted -
US 7479274
Method of administering and using VEGF inhibitors for the treatment of pancreatic carcinoma
granted -
US 7479273
Method of administering and using VEGF inhibitors for the treatment of renal cell cancer
granted -
US 7479275
Method of administering and using VEGF inhibitors for the treatment of colorectal cancer
granted -
US 7479272
Method of administering and using VEGF inhibitors for the treatment of breast cancer
granted -
US 7459426
Methods of using IL-1 antagonists to treat autoinflammatory disease
granted -
US 7449182
Therapeutic combination of a VEGF antagonist and anti-hypertensive agent
granted -
US 7417134
IL-1 receptor based cytokine traps and method of using
granted -
US 7410781
IL-4/IL-13 specific polypeptides and therapeutic uses thereof
granted -
US 7399612
VEGF-binding fusion proteins and nucleic acids encoding the same
granted